PDL BioPharma To Announce First Quarter 2009 Financial Results and Hold Conference...

PDL BioPharma To Announce First Quarter 2009 Financial Results and Hold
Conference Call May 7, 2009

INCLINE VILLAGE, Nev., April 30 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc.
(PDL) (Nasdaq: PDLI) today announced that the company will hold a conference
call and webcast on Thursday, May 7 at 4:30 p.m. Eastern Time to discuss its
financial results for the first quarter of 2009 and provide a business update.
The call and webcast will follow the release of the first quarter ended March
31, 2009 financial results after market close.

Conference Call Details
To access the live conference call on May 7 via phone, please dial (877)
361-8830 from the United States and Canada or (706) 679-8297 internationally.
The conference ID is 97783926. Please dial in approximately ten minutes prior
to the start of the call. A telephone replay will be available beginning
approximately one hour after the call through May 14, and may be accessed by
dialing (800) 642-1687 from the United States and Canada or (706) 645-9291
internationally. The replay passcode is 97783926.

To access the live and subsequently archived webcast of the conference call,
go to the company's Web site at http://www.pdl.com and click "Investors."
Please connect to the web site at least 15 minutes prior to the call to allow
for any software download that may be necessary.

About PDL BioPharma
PDL BioPharma, Inc. pioneered the humanization of monoclonal antibodies and,
by doing so, enabled the discovery of a new generation of targeted treatments
for cancer and autoimmune diseases. PDL is focused on maximizing the value of
its antibody humanization patents and related assets. The company receives
royalties on sales of a number of humanized antibody products marketed today,
and also may receive royalty payments on additional humanized antibody
products launched before patent expiry in late 2014. This press release and
further information about PDL BioPharma, Inc. can be found at: www.pdl.com.

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of
PDL BioPharma, Inc.

SOURCE PDL BioPharma, Inc.

Carolyn Wang, WeissComm Partners, +1-415-946-1065, cbwang@wcpglobal.com